Zebrafish homologs of 16p11.2, a genomic region associated with brain disorders, are active during brain development, and include two deletion dosage sensor genes
Name
Sive_Zebrafish homologs.pdf
Size
5.59 MB
Format
Adobe PDF
Checksum (MD5)
4528d551aa96effaf4cda2f6b743093f
Author(s)
Blaker-Lee, Alicia
Gupta, Sunny
McCammon, Jasmine M.
De Rienzo, Gianluca
Sive, Hazel L.
Date Issued
May 2012
Journal
Disease Models and Mechanisms
Publisher
Company of Biologists, The
Citation
Blaker-Lee, A. et al. “Zebrafish Homologs of Genes Within 16p11.2, a Genomic Region Associated with Brain Disorders, Are Active During Brain Development, and Include Two Deletion Dosage Sensor Genes.” Disease Models & Mechanisms (2012).
Version
Author's final manuscript
Abstract
Deletion or duplication of one copy of the human 16p11.2 interval is tightly associated with impaired brain function, including autism spectrum disorders (ASDs), intellectual disability disorder (IDD) and other phenotypes, indicating the importance of gene dosage in this copy number variant region (CNV). The core of this CNV includes 25 genes; however, the number of genes that contribute to these phenotypes is not known. Furthermore, genes whose functional levels change with deletion or duplication (termed 'dosage sensors'), which can associate the CNV with pathologies, have not been identified in this region. Using the zebrafish as a tool, a set of 16p11.2 homologs was identified, primarily on chromosomes 3 and 12. Use of 11 phenotypic assays, spanning the first 5 days of development, demonstrated that this set of genes is highly active, such that 21 out of the 22 homologs tested showed loss-of-function phenotypes. Most genes in this region were required for nervous system development - impacting brain morphology, eye development, axonal density or organization, and motor response. In general, human genes were able to substitute for the fish homolog, demonstrating orthology and suggesting conserved molecular pathways. In a screen for 16p11.2 genes whose function is sensitive to hemizygosity, the aldolase a (aldoaa) and kinesin family member 22 (kif22) genes were identified as giving clear phenotypes when RNA levels were reduced by ~50%, suggesting that these genes are deletion dosage sensors. This study leads to two major findings. The first is that the 16p11.2 region comprises a highly active set of genes, which could present a large genetic target and might explain why multiple brain function, and other, phenotypes are associated with this interval. The second major finding is that there are (at least) two genes with deletion dosage sensor properties among the 16p11.2 set, and these could link this CNV to brain disorders such as ASD and IDD.
MIT Department
Massachusetts Institute of Technology. School of Science
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike 3.0
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1242/dmm.009944
